메뉴 건너뛰기




Volumn 27, Issue 9, 2012, Pages 1512-1519

Non-cirrhotic portal hypertension in HIV mono-infected patients

Author keywords

Anti retroviral therapy; Human immunodeficiency virus; Liver disease; Portal hypertension

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RALTEGRAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

EID: 84865372266     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07148.x     Document Type: Article
Times cited : (10)

References (40)
  • 1
    • 61949414868 scopus 로고    scopus 로고
    • Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy
    • Ingiliz P, Valantin MA, Duvivier C etal. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Hepatology 2009; 49: 436-42.
    • (2009) Hepatology , vol.49 , pp. 436-442
    • Ingiliz, P.1    Valantin, M.A.2    Duvivier, C.3
  • 2
    • 41349094999 scopus 로고    scopus 로고
    • Performance of transient elastography for the staging of liver fibrosis: a meta-analysis
    • Friedrich-Rust M, Ong M, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
    • (2008) Gastroenterology , vol.134 , pp. 960-974
    • Friedrich-Rust, M.1    Ong, M.2    Martens, S.3
  • 3
    • 61449097678 scopus 로고    scopus 로고
    • Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection
    • Moreno S, Garcia-Samaniego J, Moreno A etal. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J. Viral Hepat. 2009; 16: 249-58.
    • (2009) J. Viral Hepat. , vol.16 , pp. 249-258
    • Moreno, S.1    Garcia-Samaniego, J.2    Moreno, A.3
  • 4
    • 34848908660 scopus 로고    scopus 로고
    • The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
    • Vergara S, Macias J, Rivero A etal. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin. Infect. Dis. 2007; 45: 969-74.
    • (2007) Clin. Infect. Dis. , vol.45 , pp. 969-974
    • Vergara, S.1    Macias, J.2    Rivero, A.3
  • 5
    • 67650450829 scopus 로고    scopus 로고
    • Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy
    • Chang PE, Miquel R, Blanco JL etal. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am. J. Gastroenterol. 2009; 104: 1707-14.
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 1707-1714
    • Chang, P.E.1    Miquel, R.2    Blanco, J.L.3
  • 6
    • 42149138423 scopus 로고    scopus 로고
    • Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
    • Maida I, Garcia-Gasco P, Sotgiu G etal. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir. Ther. 2008; 13: 103-7.
    • (2008) Antivir. Ther. , vol.13 , pp. 103-107
    • Maida, I.1    Garcia-Gasco, P.2    Sotgiu, G.3
  • 7
    • 74049108154 scopus 로고    scopus 로고
    • Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV
    • Panos G, Farouk L, Stebbing J etal. Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV. J. Acquir. Immune Defic. Syndr. 2009; 52: 525-7.
    • (2009) J. Acquir. Immune Defic. Syndr. , vol.52 , pp. 525-527
    • Panos, G.1    Farouk, L.2    Stebbing, J.3
  • 8
    • 77951880387 scopus 로고    scopus 로고
    • Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings
    • Vispo E, Moreno A, Maida I etal. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS 2010; 24: 1171-6.
    • (2010) AIDS , vol.24 , pp. 1171-1176
    • Vispo, E.1    Moreno, A.2    Maida, I.3
  • 9
    • 34247578033 scopus 로고    scopus 로고
    • Nodular regenerative hyperplasia of liver as a consequence of ART
    • Arey B, Markow M, Ravi J, Prevette E, Batts K, Nadir A. Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS 2007; 21: 1066-8.
    • (2007) AIDS , vol.21 , pp. 1066-1068
    • Arey, B.1    Markow, M.2    Ravi, J.3    Prevette, E.4    Batts, K.5    Nadir, A.6
  • 12
    • 77953394322 scopus 로고    scopus 로고
    • Noncirrhotic portal hypertension: another cause of liver disease in HIV patients
    • Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients. Ann. Hepatol. 2009; 8: 390-5.
    • (2009) Ann. Hepatol. , vol.8 , pp. 390-395
    • Mendizabal, M.1    Craviotto, S.2    Chen, T.3    Silva, M.O.4    Reddy, K.R.5
  • 13
    • 52949136988 scopus 로고    scopus 로고
    • Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection
    • Saifee S, Joelson D, Braude J etal. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin. Gastroenterol. Hepatol. 2008; 6: 1167-9.
    • (2008) Clin. Gastroenterol. Hepatol. , vol.6 , pp. 1167-1169
    • Saifee, S.1    Joelson, D.2    Braude, J.3
  • 14
    • 62649104798 scopus 로고    scopus 로고
    • Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients
    • Vispo E, Maida I, Barreiro P, Moreno V, Soriano V. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients. HIV Clin. Trials 2008; 9: 440-4.
    • (2008) HIV Clin. Trials , vol.9 , pp. 440-444
    • Vispo, E.1    Maida, I.2    Barreiro, P.3    Moreno, V.4    Soriano, V.5
  • 15
    • 49649101086 scopus 로고    scopus 로고
    • A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients
    • Tateo M, Sebagh M, Bralet M etal. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl. 2008; 14: 1194-8.
    • (2008) Liver Transpl. , vol.14 , pp. 1194-1198
    • Tateo, M.1    Sebagh, M.2    Bralet, M.3
  • 16
    • 0014495162 scopus 로고
    • Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly
    • Nayak N, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch. Pathol. 1969; 87: 359-69.
    • (1969) Arch. Pathol. , vol.87 , pp. 359-369
    • Nayak, N.1    Ramalingaswami, V.2
  • 17
    • 84987574189 scopus 로고
    • Obliterative portal venopathy: a comparison study of 184 cases of extrahepatic portal obstruction and 469 cases of idiopathic portal hypertension
    • Kameda H, Yamazaki K, Imai F, Sugiura M, Nakashima T, Okuda K. Obliterative portal venopathy: a comparison study of 184 cases of extrahepatic portal obstruction and 469 cases of idiopathic portal hypertension. J. Gastroenterol. Hepatol. 1986; 1: 139-49.
    • (1986) J. Gastroenterol. Hepatol. , vol.1 , pp. 139-149
    • Kameda, H.1    Yamazaki, K.2    Imai, F.3    Sugiura, M.4    Nakashima, T.5    Okuda, K.6
  • 18
    • 35448944283 scopus 로고    scopus 로고
    • Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV
    • Schiano T, Kotler D, Ferran E, Fiel M. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am. J. Gastroenterol. 2007; 102: 2536-40.
    • (2007) Am. J. Gastroenterol. , vol.102 , pp. 2536-2540
    • Schiano, T.1    Kotler, D.2    Ferran, E.3    Fiel, M.4
  • 19
    • 33745878829 scopus 로고    scopus 로고
    • Nodular regenerative hyperplasia: not all nodules are created equal
    • Reshamwala P, Kleiner D, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44: 7-14.
    • (2006) Hepatology , vol.44 , pp. 7-14
    • Reshamwala, P.1    Kleiner, D.2    Heller, T.3
  • 20
    • 34250890211 scopus 로고    scopus 로고
    • Response to Mallet, "Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients."
    • Garvey L, Thomson E, Lloyd J, Cooke G, Goldin R, Main J. Response to Mallet etal., "Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients." AIDS 2007; 21: 1494-5.
    • (2007) AIDS , vol.21 , pp. 1494-1495
    • Garvey, L.1    Thomson, E.2    Lloyd, J.3    Cooke, G.4    Goldin, R.5    Main, J.6
  • 21
    • 33845945366 scopus 로고    scopus 로고
    • Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients
    • Mallet VP, Blanchard V, Verkarre A etal. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21: 187-92.
    • (2007) AIDS , vol.21 , pp. 187-192
    • Mallet, V.P.1    Blanchard, V.2    Verkarre, A.3
  • 22
    • 79951681146 scopus 로고    scopus 로고
    • The role of nucleoside and nucleotide analogues in nodular regenrative hyperplasia in HIV-infected patients: a case control study
    • Cotte L, Bénet T, Billioud C etal. The role of nucleoside and nucleotide analogues in nodular regenrative hyperplasia in HIV-infected patients: a case control study. J. Hepatol. 2011; 54: 589-496.
    • (2011) J. Hepatol. , vol.54 , pp. 589-496
    • Cotte, L.1    Bénet, T.2    Billioud, C.3
  • 23
    • 67651086987 scopus 로고    scopus 로고
    • Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study
    • Kovari H, Ledergerber B, Peter U etal. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin. Infect. Dis. 2009; 49: 626-35.
    • (2009) Clin. Infect. Dis. , vol.49 , pp. 626-635
    • Kovari, H.1    Ledergerber, B.2    Peter, U.3
  • 24
    • 33845692257 scopus 로고    scopus 로고
    • Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity
    • Maida I, Soriano V, Castellares C etal. Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity. HIV Clin. Trials 2006; 7: 246-50.
    • (2006) HIV Clin. Trials , vol.7 , pp. 246-250
    • Maida, I.1    Soriano, V.2    Castellares, C.3
  • 25
    • 78149429491 scopus 로고    scopus 로고
    • Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature
    • Cesari M, Schiavini M, Marchetti G etal. Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature. AIDS Patient Care STDS 2010; 24(11): 697-703.
    • (2010) AIDS Patient Care STDS , vol.24 , Issue.11 , pp. 697-703
    • Cesari, M.1    Schiavini, M.2    Marchetti, G.3
  • 26
    • 68649114845 scopus 로고    scopus 로고
    • Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients
    • Mallet V, Varthaman A, Lasne D etal. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS 2009; 23: 1511-18.
    • (2009) AIDS , vol.23 , pp. 1511-1518
    • Mallet, V.1    Varthaman, A.2    Lasne, D.3
  • 27
    • 79951674881 scopus 로고    scopus 로고
    • Obliterative portal venopathy: portal hypertension is not always present at diagnosis
    • Cazals-Hatem D, Hillaire S, Rudler M etal. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J. Hepatol. 2011; 54: 455-61.
    • (2011) J. Hepatol. , vol.54 , pp. 455-461
    • Cazals-Hatem, D.1    Hillaire, S.2    Rudler, M.3
  • 28
    • 0032801286 scopus 로고    scopus 로고
    • Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy
    • Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol. 1999; 14: 618-33.
    • (1999) J. Gastroenterol. Hepatol. , vol.14 , pp. 618-633
    • Li, D.1    Friedman, S.L.2
  • 29
    • 77955704597 scopus 로고    scopus 로고
    • Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis
    • Tuyama A, Hong F, Saiman Y etal. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 2010; 52: 612-22.
    • (2010) Hepatology , vol.52 , pp. 612-622
    • Tuyama, A.1    Hong, F.2    Saiman, Y.3
  • 30
    • 70349577112 scopus 로고    scopus 로고
    • Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
    • Ingiliz P, Benhamou Y. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications? J. HIV Ther. 2009; 14: 3-7.
    • (2009) J. HIV Ther. , vol.14 , pp. 3-7
    • Ingiliz, P.1    Benhamou, Y.2
  • 31
    • 61949414868 scopus 로고    scopus 로고
    • Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
    • Ingiliz P, Valantin MA, Duvivier C etal. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Hepatology 2009; 49(2): 436-42.
    • (2009) Hepatology , vol.49 , Issue.2 , pp. 436-442
    • Ingiliz, P.1    Valantin, M.A.2    Duvivier, C.3
  • 33
    • 84865363769 scopus 로고    scopus 로고
    • British HIV Association guidelines for anti-retroviral treatment of HIV seropositive individuals
    • BHIVA Guidelines Co-ordinating Committee
    • BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for anti-retroviral treatment of HIV seropositive individuals. Lancet 1997; 349: 108S92.
    • (1997) Lancet , vol.349
  • 35
    • 0024349612 scopus 로고
    • In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine
    • Yarchoan R, Mitsuya H, Thomas RV etal. In vivo activity against HIV and favorable toxicity profile of 2′, 3′-dideoxyinosine. Science 1989; 245: 412-15.
    • (1989) Science , vol.245 , pp. 412-415
    • Yarchoan, R.1    Mitsuya, H.2    Thomas, R.V.3
  • 36
    • 0035810637 scopus 로고    scopus 로고
    • Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia
    • Carr A, Morey A, Mallon P, Williams D, Thorburn DR. Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia. Lancet 2001; 357: 1412-14.
    • (2001) Lancet , vol.357 , pp. 1412-1414
    • Carr, A.1    Morey, A.2    Mallon, P.3    Williams, D.4    Thorburn, D.R.5
  • 37
    • 79951726145 scopus 로고    scopus 로고
    • The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV
    • Schiano TD, Uriel A, Dieterich DT, Fiel MI. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch. 2011; 458: 231-5.
    • (2011) Virchows Arch. , vol.458 , pp. 231-235
    • Schiano, T.D.1    Uriel, A.2    Dieterich, D.T.3    Fiel, M.I.4
  • 38
    • 77956624153 scopus 로고    scopus 로고
    • Clinical syndromes and consequences of antiretroviral-related hepatotoxicity
    • Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology 2010; 52: 1143-55.
    • (2010) Hepatology , vol.52 , pp. 1143-1155
    • Nunez, M.1
  • 39
    • 78349313190 scopus 로고    scopus 로고
    • Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis
    • Francque S, Verrijken A, Mertens I etal. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur. J. Gastroentrol. Hepatol. 2010; 22: 1449-57.
    • (2010) Eur. J. Gastroentrol. Hepatol. , vol.22 , pp. 1449-1457
    • Francque, S.1    Verrijken, A.2    Mertens, I.3
  • 40
    • 39849099669 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease and the metabolic syndrome: an update
    • Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008; 14: 185-92.
    • (2008) World J. Gastroenterol. , vol.14 , pp. 185-192
    • Rector, R.S.1    Thyfault, J.P.2    Wei, Y.3    Ibdah, J.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.